CHK2-FOXK axis promotes transcriptional control of autophagy programs

Autophagy is an evolutionarily conserved catabolic process, which plays a vital role in removing misfolded proteins and clearing damaged organelles to maintain internal environment homeostasis. Here, we uncovered the checkpoint kinase 2 (CHK2)-FOXK (FOXK1 and FOXK2) axis playing an important role in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science advances 2020-01, Vol.6 (1), p.eaax5819-eaax5819
Hauptverfasser: Chen, Yuping, Wu, Jinhuan, Liang, Guang, Geng, Guohe, Zhao, Fei, Yin, Ping, Nowsheen, Somaira, Wu, Chengming, Li, Yunhui, Li, Lei, Kim, Wootae, Zhou, Qin, Huang, Jinzhou, Liu, Jiaqi, Zhang, Chao, Guo, Guijie, Deng, Min, Tu, Xinyi, Gao, Xiumei, Liu, Zhongmin, Chen, Yihan, Lou, Zhenkun, Luo, Kuntian, Yuan, Jian
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Autophagy is an evolutionarily conserved catabolic process, which plays a vital role in removing misfolded proteins and clearing damaged organelles to maintain internal environment homeostasis. Here, we uncovered the checkpoint kinase 2 (CHK2)-FOXK (FOXK1 and FOXK2) axis playing an important role in DNA damage-mediated autophagy at the transcriptional regulation layer. Mechanistically, following DNA damage, CHK2 phosphorylates FOXK and creates a 14-3-3γ binding site, which, in turn, traps FOXK proteins in the cytoplasm. Because FOXK functions as the transcription suppressor of ATGs, DNA damage-mediated FOXKs' cytoplasmic trapping induces autophagy. In addition, we found that a cancer-derived FOXK mutation induces FOXK hyperphosphorylation and enhances autophagy, resulting in chemoresistance. Cotreatment with cisplatin and chloroquine overcomes the chemoresistance caused by FOXK mutation. Overall, our study highlights a mechanism whereby DNA damage triggers autophagy by increasing autophagy genes via CHK2-FOXK-mediated transcriptional control, and misregulation of this pathway contributes to chemoresistance.
ISSN:2375-2548
2375-2548
DOI:10.1126/sciadv.aax5819